CORAL SPRINGS, Fla.--(BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain announced today that it has selected DNAA, Inc. to serve as the exclusive distributor in Panama for its Nyloxin-branded pain relievers.
